Kathryn Ruemmler, former White House counsel and longtime Goldman Sachs attorney, has been formally requested to testify before a House committee amid scrutiny over her communications with Jeffrey Epstein. The development adds legal and reputational pressure to the financial giant during a period of heightened regulatory oversight.
- Kathryn Ruemmler to testify before House Oversight Committee in late March 2026
- Over 27 emails exchanged with Jeffrey Epstein between 2013–2015
- Goldman Sachs (GS) share price: $412.30 as of March 3, 2026
- CBOE Volatility Index (VIX) rose to 18.4 amid heightened scrutiny
- Ruemmler’s departure from Goldman Sachs effective June 30, 2026
- No evidence of misconduct found in Goldman Sachs internal review
Kathryn Ruemmler, who served as a senior lawyer at Goldman Sachs from 2017 to 2024, is set to appear before a House Oversight Committee in late March 2026. The request follows the release of previously undisclosed correspondence between Ruemmler and Epstein, which surfaced during a congressional probe into financial institutions’ relationships with high-profile figures linked to criminal activity. Ruemmler announced her departure from Goldman Sachs in February 2026, with her exit effective June 30, 2026, citing personal and professional considerations. The testimony is expected to center on the nature and frequency of Ruemmler’s communications with Epstein between 2013 and 2015, during which she reportedly exchanged over 27 emails. These messages, now under review by lawmakers, include references to travel arrangements and social events, raising questions about potential lapses in due diligence by the firm. Goldman Sachs has maintained that its internal review found no evidence of improper conduct by Ruemmler or intentional risk exposure. Despite the lack of direct financial penalties or regulatory sanctions against the firm, the episode has elevated scrutiny on Wall Street’s governance practices. The S&P 500 financial sector index (XLF) has seen a 0.8% decline over the past week, while the CBOE Volatility Index (VIX) rose to 18.4, reflecting increased investor caution. Shares of Goldman Sachs (GS) traded flat at $412.30 on March 3, 2026, but sentiment remains fragile ahead of the hearing. The hearing could influence broader legislative discussions on corporate accountability, particularly regarding legal departments’ oversight of high-net-worth clients. Other firms, including JPMorgan Chase and Morgan Stanley, are also reviewing internal protocols to prevent similar reputational risks.